top of page

Latest News

I love writing guest articles and collaborating
See appearances for Asa's events and podcasts 

Oct 8, 2024

Guest Article

Asa Waldstein

Join me for SupplySide West workshop on nutritional ingredient claims, legal flames

Regulatory consultant Asa Waldstein previews a SupplySide West education session on substantiating claims and clinical trials. Waldstein is moderating the Oct. 28 session that features two attorneys and two experts from contract research organizations.

Join me for SupplySide West workshop on nutritional ingredient claims, legal flames

Oct 3, 2024

Guest Article

Asa Waldstein

Q3 2024 warning letter roundup with Asa Waldstein

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements.

Q3 2024 warning letter roundup with Asa Waldstein

Aug 19, 2024

Interview

Anthony Fletcher

AI-powered tech makes customised regulatory compliance possible

AI-powered proprietary technology could help the nutraceutical industry navigate the complexities of the regulatory world by finding – and replacing – risky marketing phrases on company websites.

AI-powered tech makes customised regulatory compliance possible

Jun 24, 2024

Interview

Josh Long

FDA, industry experts reflect on DSHEA at 30 Summit

The head of FDA's Office of Dietary Supplement Programs and a dozen others offered their perspective on the recent DSHEA at 30 Summit in Salt Lake City.

Asa Waldstein, principal, Supplement Advisory Group:


“The DSHEA Summit was a well-structured and moderated event that provided a wonderful opportunity for stakeholders in the natural wellness space to come together, appreciate and contextualize the origins and initial purposes of DSHEA, align concerning the current status of regulation in the space, and exchange ideas about what adjustments or improvements are needed. We need to use this opportunity to move forward in achieving our shared goals together. DSHEA is a remarkable statute that accomplished both expected and unexpected results. We should work to improve upon DSHEA and not simply abandon it or rush into new legislation that betrays its underlying principle of empowering consumers to make informed decisions about managing their own health and wellness.”

FDA, industry experts reflect on DSHEA at 30 Summit

Jun 4, 2024

Interview

NBJ

30 supplement industry voices suggest changes to DSHEA

Asa and other industry leaders weigh in.

Asa Waldstein, Supplement Advisory Group:


"Since DSHEA was enacted before the internet boom, I would like to see some clarification on what constitutes allowable marketing in the digital sphere. For instance, if the FDA would define the marketing compliance boundaries of reposting and social engagement and help explain why they consider a social media post from years past as active marketing, it could help companies better navigate compliance. There are also antiquated regulations that should be updated, such as 21 CFR 101.93(d), which states that the DSHEA disclaimer should be “on the same panel or page that bears the (structure/function) statement” on labels. This means that if there’s a structure/function claim on the principal display panel, then the DSHEA disclaimer should also be on the same panel. While the FDA does not seem to enforce this, plaintiff attorneys continue to cite this regulation in lawsuits, which creates unnecessary expense (and ugly labels) for supplement companies."

30 supplement industry voices suggest changes to DSHEA

May 23, 2024

Interview

Danielle Masterson

Is your age verification process in place? Everything you need to know about selling in NY

Asa and other industry experts weigh in

Is your age verification process in place? Everything you need to know about selling in NY

Apr 18, 2024

Press Mention

Niamh Michail

Revealed: The 18 finalists of the 2024 Vitafoods Europe Startup Innovation Challenge

Find out which trailblazing startups were chosen for their innovative ingredients, finished products, and technologies for the 2024 Vitafoods Europe Startup Innovation Challenge.

Revealed: The 18 finalists of the 2024 Vitafoods Europe Startup Innovation Challenge

Apr 5, 2024

Guest Article

Asa Waldstein

Q1 2024 warning letter roundup with Asa Waldstein

Dietary supplement consultant Asa Waldstein reviews regulatory trends over the last quarter in his FDA warning letter roundup column.

Q1 2024 warning letter roundup with Asa Waldstein

Feb 27, 2024

Press Mention

Stephen Daniells

Celebrating innovation

The Sports & Active Nutrition Summit also celebrated its three new Start-Up Stars, innovative early-stage companies that are disrupting the sector.

Celebrating innovation

Feb 23, 2024

Interview

Asia Sherman

FTC settles with supplement startup over COVID claims

A multi-year case involving dietary supplement startup PPO Lab, the Federal Trade Commission (FTC) and COVID-19-related health claims has come to a close, culminating in a truce that removes fines and lightens administrative burdens on the defendants.

FTC settles with supplement startup over COVID claims

Feb 15, 2024

Interview

Sarah Burden

Adapting your Business Strategy to the Regulatory Outlook

Adapting your Business Strategy to the Regulatory Outlook

Jan 22, 2024

Interview

Danielle Masterson

What can you say in weight loss claims? Experts weigh in

With what feels like a weight loss medication takeover, many are betting that the GLP-1 receptor agonists will rescue America from its obesity epidemic. So what does this mean for the natural weight loss products?

What can you say in weight loss claims? Experts weigh in

Jan 4, 2024

Interview

Danielle Masterson

New year, same problem: FDA issues tejocote root warning, finding the supplements adulterated with poisonous plant

The supplements labeled as weight loss products appear to be mislabeled as testing revealed the tejocote root was substituted with a potentially deadly plant.

New year, same problem: FDA issues tejocote root warning, finding the supplements adulterated with poisonous plant

Jan 3, 2024

Interview

Asia Sherman

Q&A: Apex Compliance founder talks streamlining supplement regulatory marketing compliance

Apex Compliance entered the dietary supplement space to simplify regulatory compliance by helping companies identify the words and phrases across marketing materials that trigger oversight agencies.

Q&A: Apex Compliance founder talks streamlining supplement regulatory marketing compliance

Jan 2, 2024

Guest Article

Asa Waldstein

Q4 warning letter roundup with Asa Waldstein

In his quarterly FDA warning letter roundup, dietary supplement consultant Asa Waldstein reviews trends over the last quarter and year, and he makes 2024 predictions.

Q4 warning letter roundup with Asa Waldstein

Oct 31, 2023

Interview

Jeff Gelski

Sales soar for probiotic-containing soft drinks

Reporting of a SupplySide West presentation

Sales soar for probiotic-containing soft drinks

Oct 10, 2023

Guest Article

Asa Waldstein

Q3 warning letter roundup with Asa Waldstein

In his quarterly FDA warning letter roundup, dietary supplement consultant Asa Waldstein reviews trends around homeopathic products, claims made in YouTube videos, delta-8 THC, and more.

Q3 warning letter roundup with Asa Waldstein

Aug 9, 2023

Interview

Nutraceutical

New software emerges to help nutrition and dietary supplement companies vet marketing claims

The software, named Apex Compliance, finds risky terms and phrases and suggests alternatives on websites, YouTube videos and in uploaded content

New software emerges to help nutrition and dietary supplement companies vet marketing claims

Aug 8, 2023

Interview

Jennifer Grebow

Regulatory compliance software helps supplement, nutrition, functional food, and cannabis brands vet their marketing claims

Called Apex Compliance, the software detects risky marketing terms and phrases and suggests lower-risk alternatives.

Regulatory compliance software helps supplement, nutrition, functional food, and cannabis brands vet their marketing claims

Jul 13, 2023

Interview

Kelly Teal

FDA targets AK Forte distributor for selling drugs, not supplements

Suprimo Imports still lists for sale products targeted by FDA in a warning letter, raising the question whether the company will face any legal or criminal action.

FDA targets AK Forte distributor for selling drugs, not supplements
bottom of page